Use of miltefosine in a patient with mucosal leishmaniasis and HIV-coinfection: a challenge in long-term management

Use of miltefosine in a patient with mucosal leishmaniasis and HIV-coinfection: a challenge in long-term management

The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limited data are available on the use of miltefosine for treatment and secondary prophylaxis. We describe a case of mucosal leishmaniasis in an HIV-coinfected patient treated with miltefosine due to a sever...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Le infezioni in medicina 2019-12, Vol.27 (4), p.452-455
Hauptverfasser: Zanelli, Giacomo, Rossetti, Barbara, Gagliardini, Roberta, Paglicci, Lorenzo, Tordini, Giacinta, Miracco, Clelia, Aversa, Sara, Zammarchi, Lorenzo, Di Muccio, Trentina, Gramiccia, Marina, Montagnani, Francesca
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limited data are available on the use of miltefosine for treatment and secondary prophylaxis. We describe a case of mucosal leishmaniasis in an HIV-coinfected patient treated with miltefosine due to a severe allergic reaction to liposomal amphotericin B.
ISSN:1124-9390